review of literature on clinical pancreatology - The Pancreapedia

560. Maemura K, Shinchi H, Noma H, Mataki Y, Kurahara H, Maeda S, Natsugoe S, Takao S.Chemoradiotherapy for locally recurrence after primary resection <strong>of</strong> biliary-pancreatic cancer. Gan ToKagaku Ryoho 2009; 36: 265-8 (in Japanese).561. Tawada K, Yamaguchi T, Kobayashi A, Ishihara T, Sudo K, Nakamura K, Hara T, Denda T,Matsuyama M, Yokosuka O. Changes in tumor vascularity depicted by contrast-enhancedultrasonography as a predictor <strong>of</strong> chemotherapeutic effect in patients with unresectable pancreaticcancer. Pancreas 2009; 38: 30-5.562. Kumagai M, Hara R, Mori S, Yanagi T, Asakura H, Kishimoto R, Kato H, Yamada S, Kandatsu S,Kamada T. Impact <strong>of</strong> intrafractional bowel gas movement on carbon ion beam dose distribution inpancreatic radiotherapy. Int J Radiat Oncol Biol Phys 2009; 73: 1276-81.563. Spry N, Bydder S, Harvey J, Borg M, Ngan S, Millar J, Graham P, Zissiadis Y, Kneebone A, EbertM. Accrediting radiation technique in a multicentre trial <strong>of</strong> chemoradiation for pancreatic cancer. J MedImaging Radiat Oncol 2008; 52: 598-604.564. Mackenzie RP, McCollum AD. Novel agents for the treatment <strong>of</strong> adenocarcinoma <strong>of</strong> thepancreas. Expert Rev Anticancer Ther 2009; 9: 1473-85.565. Abe Y, Ito T, Baba E, Nagafuji K, Kawabe K, Choi I, Arita Y, Miyamoto T, Teshima T, Nakano S,Harada M. Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy forpancreatic cancer. Pancreas 2009; 38: 815-9.566. Drag M, Surowiak P, Drag-Zalesinska M, Dietel M, Lage H, Oleksyszyn J. Comparision <strong>of</strong> thecytotoxic effects <strong>of</strong> birch bark extract, betulin and betulinic acid towards human gastric carcinoma andpancreatic carcinoma drug-sensitive and drug-resistant cell lines. Molecules 2009; 14: 1639-51.567. Sahu RP, Batra S, Srivastava SK. Activation <strong>of</strong> ATM/Chk1 by curcumin causes cell cycle arrestand apoptosis in human pancreatic cancer cells. Br J Cancer 2009; 100: 1425-33.568. Lissoni P, Rovelli F, Brivio F, Zago R, Colciago M, Messina G, Mora A, Porro G. A randomizedstudy <strong>of</strong> chemotherapy versus biochemotherapy with chemotherapy plus Aloe arborescens in patientswith metastatic cancer. In vivo 2009; 23: 171-5.569. Joo KR, Shin HP, Cha JM, Nam S, Huh Y. Effect <strong>of</strong> Korean red ginseng on superoxide dismutaseinhibitor-induced pancreatitis in rats: a histopathologic and immunohistochemical study. Pancreas2009; 38: 661-6.570. Khashab MA, Emerson RE, DeWitt JM. Endoscopic ultrasound-guided fine-needle aspiration forthe diagnosis <strong>of</strong> anaplastic pancreatic carcinoma: a single-center experience. Pancreatology 2009; 9:88-91.571. Bauer A, Kleeff J, Bier M, Wirtz M, Kayed H, Esposito I, Korc M, Hafner M, Hoheisel JH, Friess H.Identification <strong>of</strong> malignancy factors by analyzing cystic tumors <strong>of</strong> the pancreas Pancreatology 2009; 9:34-44.572. Buscaglia JM, Giday SA, Kantsevoy SV, Jagannath SB, Magno P, Wolfgang CL, Daniels JA,Canto MI, Okolo PI. Patient- and cyst-related factors for improved prediction <strong>of</strong> malignancy withincystic lesions <strong>of</strong> the pancreas. Pancreatology 2009; 9: 631-8.573. Leffler J, Krejcí T. Cystic neoplasms <strong>of</strong> the pancreas. Rozhl Chir 2008; 87: 456-8 (in Czech).574. Basturk O, Coban I, Adsay NV. Pancreatic cysts: pathologic classification, differential diagnosis,and clinical implications. Arch Pathol Lab Med 2009; 133: 423-38.575. Khalid A, Funch-Jensen P, Bendix J, Dutoit Hamilton S, Kruse A, Viborg Mortensen F. Intraductalpapillary mucinous tumor <strong>of</strong> the pancreas (IPMT): follow-up <strong>of</strong> twelve cases. Scand J Surg 2009; 98:25-9.